We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.55 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
10/10/2017 08:13 | If it's good enough for Sandgrove & Merrill it's good enough for me! | blueblood | |
10/10/2017 08:04 | If company releases nothing to aid share price I think we will probably dip sub 40p. However any news on license/debt and we'll smash through the ceiling. As soon as the market understands the company won't come back to the market to raise funds we'll be off. Can either sell not and buy back 38p but what's the point? Why run the risk of missing the re rate that will start on next positive news. | kingkongtimmo | |
10/10/2017 07:54 | Yes. Interesting charting and highlights volatility when trading mostly short term . Seems we need to break 52p according to his charting analysis to really drive up. Hope that 37p resistance isn't tested ! | 1savvyinvestor | |
10/10/2017 06:08 | Hi WD, thoroughly enjoyed reading your blog! Concise and unbiased look at the charts, thank you! Have bookmarked, will pop back again soon and have a browse | kingkongtimmo | |
10/10/2017 00:29 | Hi all, I don't hold MTFB myself but it has been getting a lot of coverage on Twitter and I thought it would be an interesting Chart to look at. Every weekend I tend to do a Charts Blog and cover a few Stocks and I shoved MTFB in this week. You can see my thoughts on it here: I hope you find it useful - I know nothing about the Fundamentals on this Stock and have purely looked at the technicals, cheers, WD. | thewheeliedealer | |
09/10/2017 15:54 | After hours in MTFB and AMP will be interesting today. | small crow | |
09/10/2017 15:53 | They do have a need for funds for HABP. However I expect that raise to be early next year, license news later this year will really kick start the share price now is the time to accumulate | kingkongtimmo | |
09/10/2017 15:49 | Or just hot money going to next spike creating weakness perhaps | dave4545 | |
09/10/2017 15:48 | They are not planning to stiff holders with another fundraising are they ? And I'm not short or long I just to not trust any company these days. | dave4545 | |
09/10/2017 13:23 | Should be double this by now imho. | le mass du pap | |
09/10/2017 13:22 | ??? free stock charts from uk.advfn.com free stock charts from uk.advfn.com | le mass du pap | |
09/10/2017 12:33 | AS will AMP. | small crow | |
09/10/2017 12:28 | Being held down.PIs stress and sell.After hours huge buys come in mopping everything up.Two holdings RNSs so far.It's so blindly obvious to me.If you can hold this share for 6-8 weeks you will do superbly well. | kingkongtimmo | |
09/10/2017 11:31 | A veritable coiled spring!! | pyglet | |
07/10/2017 10:53 | A small write up in the daily mail today, motif and immupharma mentioned both good buys, A step ahead of ImmuPharma is Motif Bio, which has successfully completed not one, but two phase III clinical trials and is preparing to submit its antibiotic, iclaprim, for regulatory sign-off. While the shares are up 23 per cent this week at around 43p, analysts think it could be worth double that figure. Amphion Innovations, the investment group, owns just over 14 per cent of Motif. Its chief executive thinks market hasn’t quite grasped how valuable this shareholding is. He might be right as Amphion’s market capitalisation is some way short of the value of its Motif investment Read more: | barriew | |
06/10/2017 15:56 | exactly Saw.What's the worst case downside risk? In my opinion mid 30p's .. if say markets decided to crash monday hahaUpside reward? ... endless.. several bags or more. | btfd | |
06/10/2017 15:36 | bottom is in and potential upside makes risk:reward is simply sublime. when the big boys have had their fill they'll let this go. rare opp for PI's... | saw89 | |
06/10/2017 15:13 | Because there's holdings being filled. Read the RNS's.. won't be the last one either. | btfd | |
06/10/2017 14:54 | Ffs how is this not rising more strongly!? | 1savvyinvestor | |
06/10/2017 14:02 | Hold on - not having that! And they banged it down with the old AT ATs. | small crow | |
06/10/2017 13:56 | There we go. Ridiculous pricing given the last two RNSs. Sometimes the market is slow indeed to catch on. A new antibiotic with at least two indications. I'm looking for £1. | brucie5 | |
06/10/2017 13:41 | Told you yesterday that wouldn't be last holding increase RNS. This is a prime takeover target. The yanks are all over it. | btfd | |
06/10/2017 13:38 | Nice growth here, happy holding. I put some cash into (HEMO) @ 3p, expecting decent growth from this bio over the years ahead. Dyor as usual | ny boy | |
06/10/2017 13:37 | No problem fella | mirabeau |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions